# Trevi Therapeutics, Inc.: Form SC 13D/A, filed Nov 8, 2024

- Company: [Trevi Therapeutics, Inc.](/companies/trvi.md) (CIK 1563880)
- Form: SC 13D/A
- Filed: 2024-11-08
- Accepted by EDGAR: Nov 8, 2024, 18:57 ET
- Period: not reported
- Accession: 0001072613-24-000813
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1563880/000107261324000813/nea16-trevi_18901.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1563880/000107261324000813/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1563880/000107261324000813/nea16-trevi_18901.htm

Filed Nov 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001072613-24-000813. Last ingested by Listed: Nov 10, 2026, 03:00 ET. No prices; not investment advice.